SEKISUI Diagnostics
Peter Reeve has extensive work experience in the field of information technology. Peter currently serves as the Associate Director of Information Technology at SEKISUI Diagnostics since July 2022. Prior to this role, they worked as a Senior Network Engineer at Connection from June 2021 to July 2022. Peter also served as the Information Technology Manager at Q-State Biosciences from September 2020 to June 2021 and as an IT Manager at Injured Workers Pharmacy from October 2018 to March 2020. Before that, they worked as a Field Services Engineer at Technical Support International (TSI) from July 2017 to June 2018 and as a Senior Services Engineer at Redfox Corporation Pty Ltd from September 2011 to June 2017.
Peter Reeve completed their education at the Manning School of Business, UMass Lowell, where they earned a Bachelor's degree in Business Administration and Management, General. This educational journey took place from 2019 to 2021. Prior to that, they attended Bentley University from 2004 to 2009, specializing in Business/Managerial Economics. However, it is important to note that no specific degree name was provided for their time at Bentley University.
This person is not in any teams
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals